MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- Scotland: Avian flu declaration near Kirriemuir, Angus on 10 January 2025 2 hours ago
- GISAID: H5N1 Bird Flu continues to take its toll in the United States 19 hours ago
- US: Presumptive Bird Flu Case Identified In San Francisco Resident 2 days ago
- US: Highly Pathogenic Avian Influenza Detected in Oakland County Flock in Michigan 3 days ago
- U.S. Department of Agriculture Announces 15 Additional States Onboard With National Milk Testing Strategy for H5N1, Shares Update on Vaccination Efforts 4 days ago
[Go Top] [Close Window]
